Literature DB >> 23872898

Microbial biotransformation of aryl sulfanylpentafluorides.

Emma Kavanagh1, Michael Winn, Cliona Nic Gabhann, Neil K O'Connor, Petr Beier, Cormac D Murphy.   

Abstract

We report, for the first time, the biotransformation of potential pollutants bearing the pentafluorosulfanyl (SF5-) functional group in a fungus and bacteria. Cunninghamella elegans transformed p-methoxy phenyl SF5 via demethylation; Pseudomonas knackmussii and P. pseudoalcaligenes KF707 transformed amino-, hydroxyamino- and diamino- substituted phenyl SF5, forming the N-acetylated derivatives as the main product. Cell-free extract of Streptomyces griseus transformed 4-amino-3-hydroxy-phenyl SF5 to the N-acetylated derivative in the presence of acetyl CoA, confirming that an N-acetyltransferase is responsible for the bacterial biotransformations. Approximately 25% of drugs and 30% of agrochemicals contain fluorine, and the trifluoromethyl group is a prominent feature of many of these since it improves lipophilicity and stability. The pentafluorosulfanyl substituent is seen as an improvement on the trifluoromethyl group and research efforts are underway to develop synthetic methods to incorporate this moiety into biologically active compounds. It is important to determine the potential environmental impact of these compounds, including the potential biotransformation reactions that may occur when they are exposed to microorganisms.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23872898     DOI: 10.1007/s11356-013-1985-2

Source DB:  PubMed          Journal:  Environ Sci Pollut Res Int        ISSN: 0944-1344            Impact factor:   4.223


  25 in total

Review 1.  The fluorinated natural products.

Authors:  D B Harper; D O'Hagan
Journal:  Nat Prod Rep       Date:  1994-04       Impact factor: 13.423

2.  Bacterial metabolism of side chain fluorinated aromatics: cometabolism of 3-trifluoromethyl(TFM)-benzoate by Pseudomonas putida (arvilla) mt-2 and Rhodococcus rubropertinctus N657.

Authors:  K H Engesser; R B Cain; H J Knackmuss
Journal:  Arch Microbiol       Date:  1988-01       Impact factor: 2.552

3.  The synthesis and biological activity of pentafluorosulfanyl analogs of fluoxetine, fenfluramine, and norfenfluramine.

Authors:  John T Welch; Dong Sung Lim
Journal:  Bioorg Med Chem       Date:  2007-08-15       Impact factor: 3.641

Review 4.  Biodegradation and biotransformation of organofluorine compounds.

Authors:  Cormac D Murphy
Journal:  Biotechnol Lett       Date:  2009-11-27       Impact factor: 2.461

5.  Phase I and phase II enzymes produced by Cunninghamella elegans for the metabolism of xenobiotics.

Authors:  D Zhang; Y Yang; J E Leakey; C E Cerniglia
Journal:  FEMS Microbiol Lett       Date:  1996-05-01       Impact factor: 2.742

6.  Metobromuron: acetylation of the aniline moiety as a detoxification mechanism.

Authors:  B G Tweedy; C Loeppky; J A Ross
Journal:  Science       Date:  1970-04-24       Impact factor: 47.728

7.  Characterization of an acetyltransferase that detoxifies aromatic chemicals in Legionella pneumophila.

Authors:  Xavier Kubiak; Delphine Dervins-Ravault; Benjamin Pluvinage; Alain F Chaffotte; Laura Gomez-Valero; Julien Dairou; Florent Busi; Jean-Marie Dupret; Carmen Buchrieser; Fernando Rodrigues-Lima
Journal:  Biochem J       Date:  2012-07-15       Impact factor: 3.857

8.  Environmental properties of pentafluorosulfanyl compounds: physical properties and photodegradation.

Authors:  Derek A Jackson; Scott A Mabury
Journal:  Environ Toxicol Chem       Date:  2009-09       Impact factor: 3.742

9.  Synthesis and biological evaluation of the first pentafluorosulfanyl analogs of mefloquine.

Authors:  Peter Wipf; Tingting Mo; Steven J Geib; Diana Caridha; Geoffrey S Dow; Lucia Gerena; Norma Roncal; Erin E Milner
Journal:  Org Biomol Chem       Date:  2009-08-07       Impact factor: 3.876

10.  Degradation of 4-fluorophenol by Arthrobacter sp. strain IF1.

Authors:  Maria Isabel M Ferreira; Julian R Marchesi; Dick B Janssen
Journal:  Appl Microbiol Biotechnol       Date:  2008-01-29       Impact factor: 4.813

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.